journal article·2021-04-21

Electron Donor–Acceptor Effect-Induced Organic/Inorganic Nanohybrids with Low Energy Gap for Highly Efficient Photothermal Therapy

Guiju Zhang, Kunle Li, Shan He, Li Wang, Shanyue Guan, Shuyun Zhou, Baocai Xu

ACS Applied Materials & Interfaces· Volume 13· Issue 15
Publisher page

Abstract

For the design and optimization of near-infrared photothermal nanohybrids, tailoring the energy gap of nanohybrids plays a crucial role in attaining a satisfactory photothermal therapeutic efficacy for cancer and remains a challenge. Herein, we report an electron donor–acceptor effect-induced organic/inorganic nanohybrid with a low energy gap (denoted as ICG/Ag/LDH) by the in situ deposition of Ag nanoparticles onto the CoAl–LDH surface, followed by the coupling of ICG. A combination study verifies that the supported Ag nanoparticles as the electron donor (D) push electrons into the conjugated system of ICG by the electronic interaction between ICG and Ag, while OH groups of LDHs as the electron acceptor (A) pull electrons from the conjugated system of ICG by hydrogen bonding (N···H–O). This induces the formation of the D–A conjugated π-system and has a strong influence on the π-conjugated system of ICG, thus leading to a prominent decrease toward the energy gap and correspondingly an ultra-long redshift (∼115 nm). The resulting ICG/Ag/LDHs show an enhanced photothermal conversion efficiency (∼45.5%) at 808 nm laser exposure, which is ∼1.6 times larger than that of ICG (∼28.4%). Such a high photothermal performance is attributed to the fact that ICG/Ag/LDHs possess a D−π–A hybrid structure and a resulting lower energy gap, thus effectively promoting nonradiative transitions and leading to enhancement of the photothermal effect. Both in vitro and in vivo results confirm the good biocompatible properties and capability of the ICG/Ag/LDHs for NIR-triggered cancer treatment. This research demonstrates a successful paradigm for the rational design and preparation of new nanohybrids through the modulation of electron donor–acceptor effect, which offers a new avenue to achieve efficient phototherapeutic agent for improving the cancer therapeutic outcomes.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Advanced Photocatalysis Techniques · Advanced Nanomaterials in Catalysis

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

School of Light Industry, Beijing Technology and Business University, 11 Fucheng Road, Haidian District, Beijing 100048, P. R. China

Key Laboratory of Photochemical Conversion and Optoelectronic Materials. Chinese Academy of Sciences, Technical Institute of Physics and Chemistry, Beijing 100190, P. R. China

Funding

Ministry of Science and Technology of the People's Republic of China · Natural Science Foundation of Beijing Municipality · Youth Innovation Promotion Association of the Chinese Academy of Sciences · National Natural Science Foundation of China

References (52)

Show source-provided references
1. 10.3390/nano1101023210.3390/nano11010232 ↗
2. 10.1002/jbio.20200015810.1002/jbio.202000158 ↗
3. 10.1039/c8cs00618k10.1039/c8cs00618k ↗
4. 10.1021/acsami.6b1126210.1021/acsami.6b11262 ↗
5. 10.1002/adfm.20180013510.1002/adfm.201800135 ↗
6. 10.1002/ange.20190837710.1002/ange.201908377 ↗
7. 10.1021/acsami.8b2063910.1021/acsami.8b20639 ↗
8. 10.1002/smll.20200244510.1002/smll.202002445 ↗
9. 10.1002/anie.20130898610.1002/anie.201308986 ↗
10. 10.1021/acsami.8b0721310.1021/acsami.8b07213 ↗
11. 10.1016/j.biomaterials.2011.06.02410.1016/j.biomaterials.2011.06.024 ↗
12. 10.1002/anie.20090261210.1002/anie.200902612 ↗
13. 10.1021/acs.chemrev.8b0040110.1021/acs.chemrev.8b00401 ↗
14. 10.1002/adfm.20140388510.1002/adfm.201403885 ↗
15. 10.1002/advs.20160054010.1002/advs.201600540 ↗
16. 10.1039/c5tb02002f10.1039/c5tb02002f ↗
17. 10.1002/smll.20160196510.1002/smll.201601965 ↗
18. Wang Z. Y. · 201310.1201/b14775 ↗
19. Steiner A. M. · Angew. Chem., Int. Ed. · 2021 · 60 · 115210.1002/anie.201916402 ↗
20. 10.1007/s12274-016-1085-y10.1007/s12274-016-1085-y ↗
21. 10.1021/ja204217210.1021/ja2042172 ↗
22. 10.1002/anie.20171294910.1002/anie.201712949 ↗
23. 10.1021/acs.jpclett.8b0045810.1021/acs.jpclett.8b00458 ↗
24. 10.1039/c3cc42137f10.1039/c3cc42137f ↗
25. 10.1039/c7nr01771e10.1039/c7nr01771e ↗
26. 10.1021/ie101152n10.1021/ie101152n ↗
27. 10.1021/ie201589410.1021/ie2015894 ↗
28. 10.1021/la400214x10.1021/la400214x ↗
29. 10.1039/c2ta01205g10.1039/c2ta01205g ↗
30. 10.1021/ja108721610.1021/ja1087216 ↗
31. 10.1021/jo500657s10.1021/jo500657s ↗
32. 10.1016/j.molstruc.2015.02.03710.1016/j.molstruc.2015.02.037 ↗
33. 10.1021/jp908145410.1021/jp9081454 ↗
34. 10.1039/c5ra23686j10.1039/c5ra23686j ↗
35. 10.1002/adma.20170738910.1002/adma.201707389 ↗
36. 10.1021/ja910088610.1021/ja9100886 ↗
37. 10.1016/j.jcat.2010.03.00810.1016/j.jcat.2010.03.008 ↗
38. Crist B. V. · 1999
39. 10.1021/j100066a02610.1021/j100066a026 ↗
40. 10.1016/j.jcat.2010.04.00410.1016/j.jcat.2010.04.004 ↗
41. Wagner C. · 1979
42. 10.1021/acsami.5b1230710.1021/acsami.5b12307 ↗
43. 10.1021/acsami.7b0736310.1021/acsami.7b07363 ↗
44. 10.1021/la000115g10.1021/la000115g ↗
45. 10.1021/acs.langmuir.8b0053510.1021/acs.langmuir.8b00535 ↗
46. 10.1021/la970490h10.1021/la970490h ↗
47. 10.1016/j.actbio.2018.09.04510.1016/j.actbio.2018.09.045 ↗
48. 10.1016/j.synthmet.2010.05.02610.1016/j.synthmet.2010.05.026 ↗
49. 10.1021/la000579e10.1021/la000579e ↗
50. 10.1002/smll.20190518410.1002/smll.201905184 ↗
51. 10.1021/acsami.9b1123810.1021/acsami.9b11238 ↗
52. 10.1038/lsa.2016.12010.1038/lsa.2016.120 ↗